Friday is National Bring Your Dog To Work Day, which aims to promote the benefits of dogs at work and raise money for All Dogs Matter, a rehoming charity. 

The initiative was set up in 2014 by Mark Hirschel and Jo Amit, the co-founders of pet product company HOWND. It gained momentum last year when Ricky Gervais lent his support.

Jo said: "We have always brought our dogs Roxy and Laila to work with us, but when we moved into new offices back in 2014 we discovered that they weren’t allowed in the premises.

"This inspired us to create an event that publicised why dogs can make a positive difference in safe work environments, in attempt to encourage companies across the UK to adopt dog friendly policies.

"We’re overwhelmed with how successful Bring Your Dog To Work Day has become. It’s been amazing to see how many people have posted their dogs at work across all social media in 2014 and 2015. Most importantly, it was fantastic to raise money for a cause that has always been close to our hearts - the wonderful work of All Dogs Matter. We’re hopeful that this year will prove even more popular, building on the momentum of 2015."

The organisers point to an American study published in 2012 which concluded that dogs at work may make a positive difference by reducing stress levels in staff and increasing their levels of job satisfaction.

For more information, visit: https://bringyourdogtoworkday.co.uk 

Protexin Veterinary has launched Cystophan, a new product to aid in the management of Feline Idiopathic Cystitis (FIC).

Protexin says nearly 50% of cats with FIC will have a recurrent signs within one year, so it is important to offer a high quality product to manage the condition correctly.

Cystophan combines 3 key ingredients in a tasty artificial chicken flavour capsule for optimum effectiveness:

• N-acetyl D-glucosamine
• Hyaluronic acid
• L-tryptophan

Cystophan is available in tubs of 30 and 240 capsules.

For further information please visit www.protexin.com.

Dechra Veterinary Products has reduced the price of two key products in its Veterinary Essentials range to help practices respond to the challenging economic climate.

Atipam 5 ml is now the same price per ml as Atipam 10ml. Used for the reversal of the sedative effects of medetomidine and dexmedetomidine in cats and dogs, practices can now choose the size that suits them best. Additionally, during January, for every 15ml purchased an extra 5ml will be provided to practices free of charge.

Thyroxyl, used for the treatment of hypothyroidism in dogs, has also been reduced in price by 15 per cent. Practices that include Thryoxyl as part of the newly introduced Essential Purchase Plan can also make further savings. 

To find out more about the Veterinary Essentials range, including further costs savings with an Essentials Purchase Plan and free margin development advice, call Liz Rawlings on 01743 441632.

A 17-year-old collie cross called Barney picked arguably the best place in the world for an old dog to fall into a canal last Saturday, when it was rescued by one of the teams taking part in the kayaking stage of the Vet Charity Challenge, an event where there were at least 150 vets on hand to help.

Barney had wandered off through an unlocked gate and fallen into the canal where he was spotted by a team from Kruuse UK. They managed to haul the struggling animal onto their kayak and take him down the canal towards a waiting group of vets and nurses. From there he was taken to Drove Vets in Swindon to make a full recovery.

Andrew Groom from Kruuse said, "It was sheer luck that we happened to be paddling past at that point. The poor chap was struggling on the steep banks of the canal and kept slipping back in. He was getting very tired and at risk of drowning, and judging by his gums and heart rate, going into shock."

Karien White from Drove Vets said: "Barney was a bit hypothermic when he was brought into us with a lot of bumps and bruises. We managed to warm him up and get him cleaned and after a little while his tail started wagging and he seemed very happy and friendly."

News of Barney was posted onto a Pewsey Facebook page which helped his worried owners trace him to the vets.

The Vet Charity Challenge took place on Saturday 27th September at St Francis School, Pewsey, near Marlborough, Wiltshire. The day consisted of 50 of teams of four orienteering, cycling and kayaking as well as undertaking mental and physical tasks. The charity raised over £70,000 in its first two years, with this year expected to boost the funds even more.

Gavin Mitchell, from founding sponsors, BCF Technology, said: "We never dreamt that while trying to raise money for our partner charities, that we would end up saving the life of a pet in such a direct fashion. Had Team Kruuse not been passing at that point, the dog would almost certainly have drowned. It highlights the real commitment and passion that the vet profession feels towards helping animals. Through our event we hope to reach out to help even more animals. People can donate directly to Vet Charity Challenge by contacting us via www.vetcharitychallenge.co.uk."

Companion Care Vets has reported a record calendar year in 2010, with 15 new surgeries opened taking the network up to 69.

Companion Care also welcomed 17 new joint venture partners, increasing the total number of partners to 87. The company expects to double the number of surgeries over the next 3 years following the announcement that it is to open standalone practices alongside the in-store Pets at Home surgeries.

According to the company, the opening of 15 new full service surgeries represents an investment of approximately £3 million during the year. More than £340,000 of that investment went on state-of-the-art digital x-ray imaging equipment - a feature of all new surgeries.

Managing director, Jane Balmain, said: "The in-store model has been hugely successful and we will continue to accelerate our growth plans for in-store surgeries as the Pets at Home store footprint expands.

"The launch of our new standalone division provides a solution for the vets and nurses who are looking for a partnership but whose preference is for a more traditional standalone style surgery. The level of interest since our announcement has been massive and we will be looking to capitalise on this in 2011 and beyond.

"Our vision is for Companion Care Vets to become a truly national leading veterinary group and with the record year in 2010 and our plans for 2011 and beyond, we are now well on the way and confident of achieving this."

Mossman Farming, a dairy farm on the west Welsh coast which has been stricken by bovine TB, has become the first to gain permission to trial PBD Biotech’s rapid Actiphage blood test for Mycobacterium bovis (M. bovis). 

PBD Biotech says the Actiphage test offers the potential to revolutionise control of bovine TB by allowing detection of the disease within hours from a blood or milk sample.

Last November, the Welsh Government announced a new policy that allowed the use of non-validated tests such as Actiphage in herds affected by a TB breakdown. It followed a similar protocol to one authorised by the UK Government last year for cattle herds in England after the test was used as part of a successful private eradication plan on a Devon dairy farm.

Mossman Farming, in Ceredigion, is located in an area of chronic breakdown. It is a spring-calving milking herd with a total stock of 529, to date 312 dairy cows have been slaughtered. Farmer Chris Mossman agreed to trial Actiphage after hearing about the Gatcombe pilot.

Chris said: "TB is a massive problem in Ceredigion, so when I heard about Actiphage’s use at Gatacombe, helping to clear that dairy herd for the first time in six years, I wanted to try and replicate those findings here. Me – and many other farmers – are losing large numbers of animals. I’m trying to do all I can to get rid of this disease from my herd."

In Spring 2019, The Office of the Chief Veterinary Officer for Wales granted permission for Robert Price-Jones MRCVS to use Actiphage to screen high-risk cattle for M. bovis.

Robert, who has been leading the trial, said: "Actiphage is able to identify the presence of relatively low numbers of M. bovis in the blood stream of infected cattle. It is not dependent upon an immune system response to the pathogen - in contrast to current validated tests - and so has greater sensitivity than such as the official Tuberculin SICCT skin test.

"The benefit of using Actiphage is that it offers the potential for eradicating the disease from the farm; as early identification of animals at risk of bovine TB enables heightened disease management and control."

Under the terms of the Welsh Government’s protocol, cattle not condemned for slaughter can be tested with Actiphage. Those that give a positive result are identified with a ‘management’ marker, monitored and milked separately.

To prevent further contamination of the environment and to minimise risk to uninfected cattle, animals found to be ‘shedders’ are removed from the farm.

Although a decision to remove cattle based on a non-validated test will be at the farmers’ own expense, the APHA (Animal and Plant Health Agency) has confirmed that during the trial, where a positive result is confirmed with statutory tests, the animals will be removed with compensation as normal.

So far, 100 animals from Mossman Farming have been tested with Actiphage and Robert Price-Jones is preparing a paper to publish the findings in early 2020.

PBD Biotech is now seeking more farms to trial Actiphage in order to gain the World Organisation for Animal Health (OIE) validation. The company is offering reduced cost testing to support trials where the findings are made available to support validation of the test.

Rabbit Awareness Week (RAW), which starts on 23rd May this year, is calling on veterinary practices to sign up to its free health check scheme to help raise awareness of rabbits' behavioural needs.

Participating practices will receive free support packs to help them advertise and run their health check events, as well as goodie bags to give out to clients who bring their rabbits in.

The 2011 event will see a PR, advertising and marketing campaign with backing from Burgess Excel and RAW partners, including Panacur Rabbit, Petplan Insurance, RSPCA, PSDA, The Blue Cross, Wood Green Animal Shelters and RWAF (Rabbit Welfare Association & Fund), which are the driving forces behind the RAW 2011 initiative.

Naomi Chatterley, marketing manager at Burgess Excel, said: "Following the success of last year's event, our aim is to create an even bigger success in 2011. This May, the focus is on raising awareness of rabbits' emotional welfare needs by encouraging owners to consider their rabbit's mental and emotional health. Rabbits that are not stimulated both mentally and physically tend to develop behavioral problems such as fur plucking, depression or severe aggression. Our sole aim is to educate owners about responsible rabbit ownership and improve the wellbeing of Britain's 3^rd most popular pet."

If you are interested in supporting RAW 2011 by hosting rabbit healthcare clinics at your surgery, please visit http://www.rabbitawarenessweek.co.uk/  to order your free support kit and register your event.

Purina has donated £100,000 to Medical Detection Dogs (MDD), to support the charity's training and potential deployment of COVID-19 sniffer dogs in public spaces.

The company is also working with the UK charity to call for the creation of international standards in the training and deployment of sniffer dogs.

Earlier this week, Medical Detection Dogs announced the findings of its research on scenting COVID-19, confirming that dogs can play a major role in public safety through their ability to detect the virus’ odour.

Researchers will now move to trial the dogs at sites such as ports of entry and public spaces, where dogs can screen individuals rather than samples and contribute to the fight against the virus by detecting COVID-19 carriers.

Sniffer dog schemes are currently being piloted in countries including Finland, Russia, Italy and France, but there is currently no centralised best practice process for such programmes.

Medical Detection Dogs and Purina are calling for:

• Time limits on deployment, to ensure that a COVID-19 detection dog will only be operationally deployed for approximately four hours over the course of an eight-hour working day. Each dog will also ideally be limited to 20-minute shifts to prevent fatigue and ensure reliable performance
• Common standards on housing for dogs to ensure dogs are not stressed or distracted by close interaction with people
• Agreed guidance for the training and deployment of future schemes around the world

Medical Detection Dogs founder and CEO Dr Claire Guest said: “Sniffer dogs have the potential to make an important contribution to the fight against COVID-19 and future pandemics. Researchers around the world are urgently working to meet that need, but it is vital that we collaborate, share the knowledge we have gained on the incredible abilities of our dogs and formalise best practice in training and deployment.

"Along with Purina we want to call for international collaboration between organisations around the world on the implementation of disease detection and research. Our vision is to guarantee that dogs are well-treated and consistent in their performance, and support the reliable, safe creation of similar schemes in developing countries, where dogs could play a huge role in halting the spread of this disease and future pandemics.”

Jeff Hamilton, CEO at Nestlé Purina PetCare EMENA, said: “Purina and Medical Detection Dogs share a belief in the positive role and impact of dogs in society.  These dogs could provide fast, effective and non-invasive diagnosis and help to create safer spaces for us all, but we should ensure that each of them is trained safely, humanely and able to effectively perform their important role in detecting COVID-19."

The Veterinary Medicines Directorate (VMD) has published its Pharmacovigilance Annual Review 2015, which reviews 5674 reports of adverse events in animals, humans and the environment following the use of veterinary medicines over the course of the year.

5638 events were reported spontaneously, mainly by the marketing authorisation holder (61%), with the remainder largely reported by veterinary surgeons. 

Of these, 5512 were reports of adverse reactions in animals: 829 concerning suspected lack of efficacy, 4638 concerning safety. The majority of reports concerned dogs (2927), cats (1426) and cattle (386).

In dogs, medicines for the control of epilepsy were most often suspected of not having performed as expected (80 reports) whilst vaccines were most commonly reported as having failed to work (71).  However, the VMD points out that in many cases, vaccination failure was attributable to other causes (such as incomplete vaccination schedule).

In cats, flea spot-on products were most likely to be reported as not having worked (21). However, there are many reasons why owners may continue to see live fleas on their animal which are unrelated to product efficacy (such as reinfestation from the environment). 

Notably, the majority of efficacy reports in horses (12/19) related to euthanasia products, which the report says should serve as a reminder that alternative means of euthanasia should always be available in case the chosen method does not proceed as planned.

Of the safety reports, 59.6% involved dogs, 31% cats, 4.9% horses and 3.9% rabbits. The majority concerned vaccines (1360 reports, most commonly general signs or symptoms, such as lethargy or pyrexia), parasiticides (472 reports, most commonly lethargy, emesis, inflammation/pruritus, depending on method of administration) and inflammation control (412 cases, most commonly emesis, renal insufficiency and diarrhoea, depending on the drug type).

There were 124 reports of adverse events in humans. Of those involving veterinary professionals (about a quarter):

• There were two cases where owners were injured by a vet with a needle. In one case, despite the owner washing and disinfecting their hands immediately, the hand became too swollen to move and required anti-histamines and anti-inflammatories.
• A veterinary nurse developed a sore eye when vaccine was squirted into it as the needle came off the syringe. The symptoms resolved the following day.
• A veterinary surgeon reported brief periods of numbness around an injury sustained from a needle used for a rabies vaccination.
• A veterinary surgeon reported injection site pain after inadvertently injecting a small volume of a macrolide antimicrobial into his thumb. 
• A veterinary surgeon scratched his finger with a needle he had used to administer tilmicosin, and he thought a drop may have entered the wound. Nevertheless he did not seek medical attention until more than 3 hours later. Fortunately no treatment was required. 
• A veterinary surgeon pricked her finger with a needle on a syringe full of alfaxalone. No product was injected and she experienced no other symptoms than bleeding and pain from the puncture wound. 
• A veterinary surgeon was administering pentobarbital to a cat when the needle came off the syringe and between 1 and 20 ml of product squirted back into her eyes and mouth. She rinsed her eyes and mouth, drank some water and ate a banana. 45 minutes later she felt tired and ‘fuzzy’. She spoke to her GP by phone, but did not attend the surgery or receive treatment. She recovered within 3 hours. 
• A locum veterinary nurse developed swelling around an injury on her hand from a needle on a syringe of medetomidine. She had punctured a blood vessel, but thought only a small amount of product was injected. She felt light-headed and was monitored in hospital for a couple of hours, after which she returned to work with no lasting effects. 
• Two veterinary surgeons and a pet owner suffered needle stick injuries whilst an anti-emetic was administered to an animal that was being restrained by the owner. 

The VMD says that reports of needle stick injuries involving vaccines with a mineral oil adjuvant are of particular concern, because they often fail to show that the injured party has received prompt and correct treatment, either because they are themselves unaware of the necessity for swift intervention, or because they do not take the product package information leaflet with them when seeking medical treatment. 

Similarly, the VMD says that incidents involving injectable tilmicosin seem to be often dismissed as just a scratch, and that if you use these products, you should make sure you are fully aware of the warnings contained in the product leaflets.

To read the full report, visit: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/608968/PhV_Annual_Review_2015_v7.pdf 

North Star Vets, which launched last year with a business model that gives head vets at each practice a stake in the business, has opened two new sites in Sandymoor and Warrington.

Sandymoor Vets and Westbrook Vets are headed by Clinic directors, Dr Becky Crossfield and Dr Rhys Peters, supported by a team of 18 vets, nurses and receptionists at each practice and a six-strong head office support team providing finance, marketing, property and HR expertise.

North Star Vets which was launched by Dr Sean Cleary, Dr Richard Thomas and chartered accountant, Jane Platt, opened its first practice about 11 months ago. 

The company is aiming to grow to 10 practices over the next four years.

Sea, said: “The ethos of North Star Vets is about giving the next generation of ambitious vets an opportunity to own a share of their own practice and to run it the way they want, without the risk and substantial capital investment that would usually be required to open their own site.

“Our practices also have the added benefit of our central resources spanning clinical, financial, HR, marketing, procurement and property expertise, which are all required to create a successful business.

"In addition, clients enjoy the service levels and continuity that owner managed businesses are renowned for.”

“We knew our offering would be attractive to high quality vets who have the ambition and drive to go beyond heading up a corporate practice, and want to take their career, experience and earning potential to the next level.

“Burford Lane Vets has been very successful achieving a monthly turnover of £100,000 within its first 12 months and we’re very pleased to follow this with the opening of Westbrook Vets and Sandymoor Vets.

"Both practices are in great locations and have undergone high quality fit outs that incorporate all the latest equipment and facilities.

"When this is combined with the knowledge, experience and enthusiasm of Becky and Rhys, it’s easy to see why both practices are proving popular, with almost 700 clients already registered at Westbrook Vets and more than 400 at Sandymoor Vets.

“We’re already planning to open two more sites in the North West, and are currently looking for high-calibre vets who want to be masters of their own destiny by becoming part of our unique co-ownership model.

"Anyone interested should contact us now.”

www.northstarvets.co.uk

Veterinary Insights, a business intelligence provider, says it calculates that revenue in UK companion animal practices has now recovered to 82% of pre-lockdown levels.

Veterinary Insights gets its data from over 400 practices using Vet Viewer, its benchmarking software which practices use to monitor business metrics.

Apparently, the figures show that while overall turnover has bounced back relatively robustly, sales in certain areas are still lagging, reflecting changed routines in the ‘new normal’. For example, with many practices requesting clients wait in the car park, there has been a sustained drop in the sale of products typically sold in the waiting room, with sales of pet food falling by 44% during early lockdown, and still down by 25% compared with February’s figures.

The company says there are also significant business stresses that may not be captured in current revenue data.

Alexander Arpino, Managing Director of Veterinary Insights, said: “Anecdotally, we’re hearing that vets are increasingly hard-pressed for time, with logistical difficulties arising from social distancing. Consults are taking longer, and there’s an additional headache for receptionists as payments have to be collected afterwards over the phone. While there are some quick fixes, for example using a telemedicine app such as LinkyVet that sets payment expectations up front, there is no doubt that it’s difficult to make all this extra time investment sustainable in the long run.”

Paradoxically, while consults may be taking up more of vets’ time, some clients feel that they are getting less value for money as there is little face-to-face interaction with the vet. Alexander added: "One of the biggest challenges in the current environment is preserving and fostering those positive relationships with clients that are the cornerstone of companion animal practice.

"Ultimately, we want to bring clients back into the consult room, but only as and when it’s safe to do so. Otherwise, the question is: How can we make adjustments to maintain a high level of client satisfaction, without putting undue stress on vets?"

Veterinary Insights says its software can help practices navigate these challenges by presenting up to 24 months of historical data extracted from practice management systems, enabling businesses to draw comparisons with past performance.

For more information, visit www.vetviewer.co.uk.

MSD Animal Health showed off Expertis LivestockPro, its new digital flock health management tool, to sheep producers at the NSA Sheep Event last week. 

Expertis LivestockPro is an online website-based computer application designed to make flock vaccine and animal health product scheduling much simpler. MSD says it will provide a platform for vets to help their customers improve flock performance and productivity.

Project co-ordinator Marcus Sanders from MSD Animal Health, said: "Expertis LivestockPro really will make life easier for UK sheep producers. Shepherds will no longer have to rely on memory or written records in a filing cabinet or on a farm office wallchart to schedule animal health treatments.  Embracing the new digital system will certainly save time and money, and ultimately reduce livestock losses from key sheep diseases."

The new application also keeps track of vaccine stock levels on the farm and reminds users to order additional product before it is needed. Users can set up various alerts on any Internet-connected device. LivestockPro also incorporates medicinal product information and advice on correct vaccine administration.

For more information, visit www.livestockpro.co.uk or e-mail MSD Animal Health [livestockpro@merck.com].